StockData

BioLargo, Inc. (BLGO) stock

BLGOOTCChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 0/30
$0.07+0.00 (+0.90%)

Close on Oct 19, 2026Market cap $23.27MP/E –Yield –

BioLargo gross margin

Gross margin is gross profit as a percentage of revenue.

BioLargo's gross margin for the twelve months ending Jun 30, 2026 was 40.0%. For fiscal 2025 it was 43.9%, against 44.2% the year before. The highest annual figure on record is 82.3% in fiscal 2013.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202543.9%−0.3
FY2024Dec 31, 202444.2%−6.1
FY2023Dec 31, 202350.3%+1.8
FY2022Dec 31, 202248.6%+5.0
FY2021Dec 31, 202143.6%−6.9
FY2020Dec 31, 202050.5%+1.3
FY2019Dec 31, 201949.2%+3.7
FY2018Dec 31, 201845.5%+8.1
FY2017Dec 31, 201737.4%−24.9
FY2016Dec 31, 201662.3%+11.0
FY2015Dec 31, 201551.4%+1.6
FY2014Dec 31, 201449.8%−32.5
FY2013Dec 31, 201382.3%+43.0
FY2012Dec 31, 201239.3%−32.0
FY2011Dec 31, 201171.3%+51.4
FY2010Dec 31, 201020.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202654.1%+2.9
Q1 FY2026Mar 31, 202641.1%−4.4
Q4 FY2025Dec 31, 202520.7%−27.1
Q3 FY2025Sep 30, 202533.7%−5.9
Q2 FY2025Jun 30, 202551.2%+8.5
Q1 FY2025Mar 31, 202545.5%−1.7
Q4 FY2024Dec 31, 202447.9%+0.1
Q3 FY2024Sep 30, 202439.6%−14.1
Q2 FY2024Jun 30, 202442.6%−14.0
Q1 FY2024Mar 31, 202447.2%−1.2
Q4 FY2023Dec 31, 202347.8%+1.8
Q3 FY2023Sep 30, 202353.7%+3.6
Q2 FY2023Jun 30, 202356.6%+9.5
Q1 FY2023Mar 31, 202348.4%−5.6
Q4 FY2022Dec 31, 202246.0%+5.0
Q3 FY2022Sep 30, 202250.1%+1.0
Q2 FY2022Jun 30, 202247.1%+3.8
Q1 FY2022Mar 31, 202254.0%+13.4
Q4 FY2021Dec 31, 202141.0%−10.3
Q3 FY2021Sep 30, 202149.2%−5.6
Q2 FY2021Jun 30, 202143.3%−8.6
Q1 FY2021Mar 31, 202140.6%−0.1
Q4 FY2020Dec 31, 202051.3%−0.5
Q3 FY2020Sep 30, 202054.8%+4.6
Q2 FY2020Jun 30, 202051.9%+5.4
Q1 FY2020Mar 31, 202040.8%−6.5
Q4 FY2019Dec 31, 201951.8%+3.5
Q3 FY2019Sep 30, 201950.2%−5.8
Q2 FY2019Jun 30, 201946.5%+7.9
Q1 FY2019Mar 31, 201947.3%+19.8
Q4 FY2018Dec 31, 201848.3%+0.7
Q3 FY2018Sep 30, 201856.0%+27.6
Q2 FY2018Jun 30, 201838.5%+11.9
Q1 FY2018Mar 31, 201827.5%−23.6
Q4 FY2017Dec 31, 201747.6%+3.6
Q3 FY2017Sep 30, 201728.3%−42.6
Q2 FY2017Jun 30, 201726.6%–
Q1 FY2017Mar 31, 201751.0%–
Q4 FY2016Dec 31, 201643.9%–
Q3 FY2016Sep 30, 201671.0%–

More BioLargo figures

See a number that looks wrong?